Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B Study

In AIDS Clinical Trials Group A5202, participants who reported missing their medication within the past month or not providing adherence reports at both 8 and 24 weeks had 5 times the hazard of virological failure compared to more adherent participants. Adherence interventions should focus on such p...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Robert A., Rabideau, Dustin J., Sax, Paul E., Tierney, Camlin, Daar, Eric S., Collier, Ann C., Losina, Elena, Freedberg, Kenneth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434358/
https://www.ncbi.nlm.nih.gov/pubmed/28329243
http://dx.doi.org/10.1093/cid/cix176
Descripción
Sumario:In AIDS Clinical Trials Group A5202, participants who reported missing their medication within the past month or not providing adherence reports at both 8 and 24 weeks had 5 times the hazard of virological failure compared to more adherent participants. Adherence interventions should focus on such patients.

Ejemplares similares